Araştırma Makalesi

Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS

Cilt: 12 Sayı: 2 31 Ağustos 2022
  • İrem Yıldırım *
  • Halit Güneş
  • Kürşat Usalan
PDF İndir
EN

Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS

Öz

Aim: Stroke is the most common neurological cause of morbidity and mortality worldwide. Therefore, controlling the risk factors in an early phase is critically important. In this study, we aimed to investigate the advantages of neutrophile lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) values against each other in predicting the prognosis of ischemic stroke. Material and Method: 143 ischemic stroke patients were included in to study. Blood sample analysis was done to calculate NLR and PLR. Patients’ NIHSS at first admission was also calculated. Multiple statistical analyses were used to analyze the statistical significance of NLR and PLR’s predictive power in poor prognosis. Results: We found that NLR was lower in those with a stroke scale score of 5 and below; the difference was statistically significant (p=0.015). The results of the ROC curve analysis showed that the NLR value was statistically significant in predicting patients categorized as NIHSS 6 and above (p<0.001). Conclusion: This study is one of the first in the literature to evaluate the advantages of NLR and PLR values against one another in predicting stroke prognosis. Results show that the NLR value has a higher statistical significance in predicting prognosis than the PLR value. It is believed that prospective randomized studies can draw more meaningful conclusions on a larger set of patients.

Anahtar Kelimeler

Kaynakça

  1. 1. Xue J, Huang W, Chen X, Li Q, Cai Z, Yu T et al. Neutrophilto-Lymphocyte Ratio Is a Prognostic Marker in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017;26(3):650–657. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.010 Epub 2016 Dec 9. PMID: 27955949.
  2. 2. Balta S, Demırkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int. 2013;17(4):668–9. doi: 10.1111/hdi.12058 Epub 2013 Jun 14. PMID: 23763539.
  3. 3. Icme F, San I, Yuzbasioglu Y. The prognostic relationship between complete blood count parameters and infarct positive transient ischemic attack, infarct negative transient ischemic attack and ischemic stroke, Acta Med Mediterr. 2016;32:97.
  4. 4. Tokgoz S, Kayrak M, Akpinar Z, Seyithanoğlu A, Güney F, Yuruten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis. 2013;22(7):1169–74. doi: 10.1016/j. jstrokecerebrovasdis.2013.01.011 Epub 2013 Mar 14. PMID: 23498372.
  5. 5. Altintas O, Altintas MO, Tasal A, Kucukdagli OT, Asil T. The relationship of platelet-to-lymphocyte ratio with clinical outcome and final infarct core in acute ischemic stroke patients who have undergone endovascular therapy. Neurol Res. 2016;38(9):759–65. doi: 10.1080/01616412.2016.1215030 Epub 2016 Jul 30. PMID: 27477691.
  6. 6. Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M. Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci. 2018;387:115–118. doi: 10.1016/j. jns.2018.02.002 Epub 2018 Feb 2. PMID: 29571846.
  7. 7. Jiang H, Zhang J, Wu J, Wei G, He Y, Gao X. Neutrophil-toLymphocyte Ratio Correlates with Severity of Extracranial Carotid Stenosis-A Study Using Digital Subtraction Angiography. J Stroke Cerebrovasc Dis. 2017;26(6):1182– 1190. doi:10.1016/j.jstrokecerebrovasdis.2017.01.002 Epub 2017 Mar 6. PMID: 28279551.
  8. 8. Lim HH, Jeong IH, An GD, Woo KS, Kim KH, Kim JM, et al. Early prediction of severity in acute ischemic stroke and transient ischemic attack using platelet parameters and neutrophil-tolymphocyte ratio. J Clin Lab Anal. 2019;33(3):e22714. doi: 10.1002/jcla.22714 Epub 2018 Nov 9. PMID: 30411816; PMCID: PMC6818602.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yazarlar

İrem Yıldırım * Bu kişi benim
0000-0002-5623-7408
Türkiye

Yayımlanma Tarihi

31 Ağustos 2022

Gönderilme Tarihi

13 Mayıs 2021

Kabul Tarihi

24 Temmuz 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 12 Sayı: 2

Kaynak Göster

APA
Yıldırım, İ., Güneş, H., & Usalan, K. (2022). Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS. Kafkas Journal of Medical Sciences, 12(2), 93-97. https://izlik.org/JA43ZZ47CY
AMA
1.Yıldırım İ, Güneş H, Usalan K. Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS. KAFKAS TIP BİL DERG. 2022;12(2):93-97. https://izlik.org/JA43ZZ47CY
Chicago
Yıldırım, İrem, Halit Güneş, ve Kürşat Usalan. 2022. “Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS”. Kafkas Journal of Medical Sciences 12 (2): 93-97. https://izlik.org/JA43ZZ47CY.
EndNote
Yıldırım İ, Güneş H, Usalan K (01 Ağustos 2022) Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS. Kafkas Journal of Medical Sciences 12 2 93–97.
IEEE
[1]İ. Yıldırım, H. Güneş, ve K. Usalan, “Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS”, KAFKAS TIP BİL DERG, c. 12, sy 2, ss. 93–97, Ağu. 2022, [çevrimiçi]. Erişim adresi: https://izlik.org/JA43ZZ47CY
ISNAD
Yıldırım, İrem - Güneş, Halit - Usalan, Kürşat. “Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS”. Kafkas Journal of Medical Sciences 12/2 (01 Ağustos 2022): 93-97. https://izlik.org/JA43ZZ47CY.
JAMA
1.Yıldırım İ, Güneş H, Usalan K. Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS. KAFKAS TIP BİL DERG. 2022;12:93–97.
MLA
Yıldırım, İrem, vd. “Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS”. Kafkas Journal of Medical Sciences, c. 12, sy 2, Ağustos 2022, ss. 93-97, https://izlik.org/JA43ZZ47CY.
Vancouver
1.İrem Yıldırım, Halit Güneş, Kürşat Usalan. Evaluation of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratio Values in Patients with Ischemic Stroke in Terms of Disease Severity Based on NIHSS. KAFKAS TIP BİL DERG [Internet]. 01 Ağustos 2022;12(2):93-7. Erişim adresi: https://izlik.org/JA43ZZ47CY